SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '38Z'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HYY_D_STID600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	VAL A 56 ALA A 69 ILE A 91 ILE A 120 LEU A 173 ASP A 184	None 38Z A 418 (-3.4A) None None 38Z A 418 (-4.4A) 38Z A 418 (-3.5A)	1.04A	2hyyD-4qtbA: 21.6	2hyyD-4qtbA: 22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_A_B49A1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	7 / 12	ILE A 48 VAL A 56 ALA A 69 ILE A 101 LEU A 124 MET A 125 LEU A 173	38Z A 418 ( 4.4A) None 38Z A 418 (-3.4A) 38Z A 418 ( 4.9A) 38Z A 418 ( 4.8A) None 38Z A 418 (-4.4A)	0.44A	2y7jA-4qtbA: 27.9	2y7jA-4qtbA: 27.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_B_B49B1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	7 / 10	ILE A 48 VAL A 56 ALA A 69 ILE A 101 LEU A 124 MET A 125 LEU A 173	38Z A 418 ( 4.4A) None 38Z A 418 (-3.4A) 38Z A 418 ( 4.9A) 38Z A 418 ( 4.8A) None 38Z A 418 (-4.4A)	0.46A	2y7jB-4qtbA: 21.1	2y7jB-4qtbA: 27.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	7 / 10	ILE A 48 VAL A 56 ALA A 69 ILE A 101 LEU A 124 MET A 125 LEU A 173	38Z A 418 ( 4.4A) None 38Z A 418 (-3.4A) 38Z A 418 ( 4.9A) 38Z A 418 ( 4.8A) None 38Z A 418 (-4.4A)	0.45A	2y7jC-4qtbA: 27.9	2y7jC-4qtbA: 27.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_D_B49D1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	7 / 10	ILE A 48 VAL A 56 ALA A 69 ILE A 101 LEU A 124 MET A 125 LEU A 173	38Z A 418 ( 4.4A) None 38Z A 418 (-3.4A) 38Z A 418 ( 4.9A) 38Z A 418 ( 4.8A) None 38Z A 418 (-4.4A)	0.47A	2y7jD-4qtbA: 27.8	2y7jD-4qtbA: 27.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	VAL A 56 ALA A 69 GLU A 88 LEU A 92 ILE A 101	None 38Z A 418 (-3.4A) 38Z A 418 (-3.4A) None 38Z A 418 ( 4.9A)	1.01A	3gcsA-4qtbA: 28.1	3gcsA-4qtbA: 47.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	VAL A 56 ALA A 69 GLU A 88 LEU A 92 ILE A 101 ASP A 184	None 38Z A 418 (-3.4A) 38Z A 418 (-3.4A) None 38Z A 418 ( 4.9A) 38Z A 418 (-3.5A)	1.18A	3gp0A-4qtbA: 37.4	3gp0A-4qtbA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	VAL A 56 ALA A 69 LEU A 92 ILE A 101 HIS A 164 ASP A 184	None 38Z A 418 (-3.4A) None 38Z A 418 ( 4.9A) None 38Z A 418 (-3.5A)	1.07A	3gp0A-4qtbA: 37.4	3gp0A-4qtbA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	VAL A 56 ALA A 69 LYS A 71 GLU A 88 ILE A 101 ILE A 157	None 38Z A 418 (-3.4A) 38Z A 418 (-2.9A) 38Z A 418 (-3.4A) 38Z A 418 ( 4.9A) None	1.17A	3hegA-4qtbA: 37.3	3hegA-4qtbA: 47.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	VAL A 56 ALA A 69 LYS A 71 GLU A 88 LEU A 92 ILE A 101	None 38Z A 418 (-3.4A) 38Z A 418 (-2.9A) 38Z A 418 (-3.4A) None 38Z A 418 ( 4.9A)	1.12A	3hegA-4qtbA: 37.3	3hegA-4qtbA: 47.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V5W_A_8PRA701_1 (G-PROTEIN COUPLED RECEPTOR KINASE 2)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	ILE A 48 GLY A 54 VAL A 56 ALA A 69 LYS A 71 LEU A 173	38Z A 418 ( 4.4A) None None 38Z A 418 (-3.4A) 38Z A 418 (-2.9A) 38Z A 418 (-4.4A)	0.86A	3v5wA-4qtbA: 8.7	3v5wA-4qtbA: 22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZE_A_BAXA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	5 / 8	VAL A 100 LEU A 173 ILE A 182 CYH A 183 ASP A 184	None 38Z A 418 (-4.4A) None 38Z A 418 ( 3.8A) 38Z A 418 (-3.5A)	0.62A	3wzeA-4qtbA: 21.5	3wzeA-4qtbA: 26.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZBF_A_VGHA3000_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	ALA A 69 LEU A 124 MET A 125 ASP A 128 LEU A 173	38Z A 418 (-3.4A) 38Z A 418 ( 4.8A) None EDO A 413 (-2.9A) 38Z A 418 (-4.4A)	0.55A	3zbfA-4qtbA: 23.3	3zbfA-4qtbA: 25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ASD_A_BAXA1500_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	4 / 6	ILE A 91 LEU A 173 ILE A 182 CYH A 183	None 38Z A 418 (-4.4A) None 38Z A 418 ( 3.8A)	0.81A	4asdA-4qtbA: 21.1	4asdA-4qtbA: 26.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	7 / 12	ALA A 69 LYS A 71 LEU A 92 ILE A 120 HIS A 164 LEU A 173 ASP A 184	38Z A 418 (-3.4A) 38Z A 418 (-2.9A) None None None 38Z A 418 (-4.4A) 38Z A 418 (-3.5A)	1.11A	4c8bA-4qtbA: 22.0	4c8bA-4qtbA: 25.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	8 / 12	VAL A 56 ALA A 69 ILE A 101 ASP A 128 ASP A 166 LYS A 168 ASN A 171 LEU A 173	None 38Z A 418 (-3.4A) 38Z A 418 ( 4.9A) EDO A 413 (-2.9A) None EDO A 405 ( 4.3A) None 38Z A 418 (-4.4A)	0.81A	4i41A-4qtbA: 25.5	4i41A-4qtbA: 25.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	8 / 12	VAL A 56 ILE A 101 ASP A 128 ASP A 166 LYS A 168 ASN A 171 LEU A 173 ASP A 184	None 38Z A 418 ( 4.9A) EDO A 413 (-2.9A) None EDO A 405 ( 4.3A) None 38Z A 418 (-4.4A) 38Z A 418 (-3.5A)	0.78A	4i41A-4qtbA: 25.5	4i41A-4qtbA: 25.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OGR_A_ADNA401_1 (CYCLIN-DEPENDENT KINASE 9)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	6 / 8	ILE A 48 VAL A 56 ALA A 69 ASP A 128 ASN A 171 LEU A 173	38Z A 418 ( 4.4A) None 38Z A 418 (-3.4A) EDO A 413 (-2.9A) None 38Z A 418 (-4.4A)	0.64A	4ogrA-4qtbA: 31.1	4ogrA-4qtbA: 31.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OGR_I_ADNI401_1 (CYCLIN-DEPENDENT KINASE 9)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	6 / 9	ILE A 48 VAL A 56 ALA A 69 ASP A 128 ASN A 171 LEU A 173	38Z A 418 ( 4.4A) None 38Z A 418 (-3.4A) EDO A 413 (-2.9A) None 38Z A 418 (-4.4A)	0.65A	4ogrI-4qtbA: 31.2	4ogrI-4qtbA: 31.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U0I_A_0LIA1001_2 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	7 / 12	ALA A 69 LYS A 71 LEU A 92 HIS A 164 LEU A 173 CYH A 183 ASP A 184	38Z A 418 (-3.4A) 38Z A 418 (-2.9A) None None 38Z A 418 (-4.4A) 38Z A 418 ( 3.8A) 38Z A 418 (-3.5A)	1.17A	4u0iA-4qtbA: 21.4	4u0iA-4qtbA: 22.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XOY_A_DX4A401_0 (MITOGEN-ACTIVATED PROTEIN KINASE 1)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	5 / 6	ALA A 69 GLN A 122 LEU A 124 MET A 125 LEU A 173	38Z A 418 (-3.4A) 38Z A 418 (-3.7A) 38Z A 418 ( 4.8A) None 38Z A 418 (-4.4A)	0.21A	4xoyA-4qtbA: 19.0	4xoyA-4qtbA: 85.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XP3_A_DX4A401_0 (MITOGEN-ACTIVATED PROTEIN KINASE 1)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	5 / 6	ALA A 69 GLN A 122 LEU A 124 MET A 125 LEU A 173	38Z A 418 (-3.4A) 38Z A 418 (-3.7A) 38Z A 418 ( 4.8A) None 38Z A 418 (-4.4A)	0.32A	4xp3A-4qtbA: 50.5	4xp3A-4qtbA: 85.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HES_A_032A401_1 (MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	VAL A 56 ALA A 69 ILE A 101 ILE A 120 CYH A 183	None 38Z A 418 (-3.4A) 38Z A 418 ( 4.9A) None 38Z A 418 ( 3.8A)	0.68A	5hesA-4qtbA: 20.3	5hesA-4qtbA: 27.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	7 / 12	ILE A 48 GLY A 49 TYR A 53 VAL A 56 ALA A 69 ASP A 128 LEU A 173	38Z A 418 ( 4.4A) None 38Z A 418 (-3.5A) None 38Z A 418 (-3.4A) EDO A 413 (-2.9A) 38Z A 418 (-4.4A)	0.75A	5l2iA-4qtbA: 14.0	5l2iA-4qtbA: 34.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	6 / 9	ILE A 48 GLY A 49 VAL A 56 ALA A 69 ILE A 101 MET A 125	38Z A 418 ( 4.4A) None None 38Z A 418 (-3.4A) 38Z A 418 ( 4.9A) None	0.62A	5lw1B-4qtbA: 26.0	5lw1B-4qtbA: 10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_E_ADNE401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	6 / 10	GLY A 49 VAL A 56 ALA A 69 ILE A 101 LEU A 124 MET A 125	None None 38Z A 418 (-3.4A) 38Z A 418 ( 4.9A) 38Z A 418 ( 4.8A) None	0.54A	5lw1E-4qtbA: 24.6	5lw1E-4qtbA: 10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_H_ADNH401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	5 / 9	GLY A 49 VAL A 56 ALA A 69 LEU A 124 MET A 125	None None 38Z A 418 (-3.4A) 38Z A 418 ( 4.8A) None	0.41A	5lw1H-4qtbA: 37.8	5lw1H-4qtbA: 10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_F_CVIF301_1 (REGULATORY PROTEIN TETR)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	4 / 8	ILE A 91 GLN A 122 VAL A 100 ASP A 227	None 38Z A 418 (-3.7A) None None	1.14A	5vlmF-4qtbA: undetectable	5vlmF-4qtbA: 20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FNM_A_1N1A1001_1 (-)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	7 / 12	ILE A 48 VAL A 56 ALA A 69 GLU A 88 ILE A 120 MET A 125 LEU A 173	38Z A 418 ( 4.4A) None 38Z A 418 (-3.4A) 38Z A 418 (-3.4A) None None 38Z A 418 (-4.4A)	0.88A	6fnmA-4qtbA: 17.3	6fnmA-4qtbA: 26.58

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["2HYY_D_STID600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",6,"VAL A  56;ALA A  69;ILE A  91;ILE A 120;LEU A 173;ASP A 184","None;38Z A 418 (-3.4A);None;None;38Z A 418 (-4.4A);38Z A 418 (-3.5A)","1.04A","2hyyD-4qtbA:21.6",null],["2Y7J_A_B49A1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",7,"ILE A  48;VAL A  56;ALA A  69;ILE A 101;LEU A 124;MET A 125;LEU A 173","38Z A 418 ( 4.4A);None;38Z A 418 (-3.4A);38Z A 418 ( 4.9A);38Z A 418 ( 4.8A);None;38Z A 418 (-4.4A)","0.44A","2y7jA-4qtbA:27.9","2hyyD-4qtbA:22.63"],["2Y7J_B_B49B1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",7,"ILE A  48;VAL A  56;ALA A  69;ILE A 101;LEU A 124;MET A 125;LEU A 173","38Z A 418 ( 4.4A);None;38Z A 418 (-3.4A);38Z A 418 ( 4.9A);38Z A 418 ( 4.8A);None;38Z A 418 (-4.4A)","0.46A","2y7jB-4qtbA:21.1","2y7jA-4qtbA:27.85"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",7,"ILE A  48;VAL A  56;ALA A  69;ILE A 101;LEU A 124;MET A 125;LEU A 173","38Z A 418 ( 4.4A);None;38Z A 418 (-3.4A);38Z A 418 ( 4.9A);38Z A 418 ( 4.8A);None;38Z A 418 (-4.4A)","0.45A","2y7jC-4qtbA:27.9","2y7jB-4qtbA:27.85"],["2Y7J_D_B49D1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",7,"ILE A  48;VAL A  56;ALA A  69;ILE A 101;LEU A 124;MET A 125;LEU A 173","38Z A 418 ( 4.4A);None;38Z A 418 (-3.4A);38Z A 418 ( 4.9A);38Z A 418 ( 4.8A);None;38Z A 418 (-4.4A)","0.47A","2y7jD-4qtbA:27.8","2y7jC-4qtbA:27.85"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",5,"VAL A  56;ALA A  69;GLU A  88;LEU A  92;ILE A 101","None;38Z A 418 (-3.4A);38Z A 418 (-3.4A);None;38Z A 418 ( 4.9A)","1.01A","3gcsA-4qtbA:28.1","2y7jD-4qtbA:27.85"],["3GP0_A_NILA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 11","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",6,"VAL A  56;ALA A  69;GLU A  88;LEU A  92;ILE A 101;ASP A 184","None;38Z A 418 (-3.4A);38Z A 418 (-3.4A);None;38Z A 418 ( 4.9A);38Z A 418 (-3.5A)","1.18A","3gp0A-4qtbA:37.4","3gcsA-4qtbA:47.06"],["3GP0_A_NILA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 11","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",6,"VAL A  56;ALA A  69;LEU A  92;ILE A 101;HIS A 164;ASP A 184","None;38Z A 418 (-3.4A);None;38Z A 418 ( 4.9A);None;38Z A 418 (-3.5A)","1.07A","3gp0A-4qtbA:37.4","3gp0A-4qtbA:45.74"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",6,"VAL A  56;ALA A  69;LYS A  71;GLU A  88;ILE A 101;ILE A 157","None;38Z A 418 (-3.4A);38Z A 418 (-2.9A);38Z A 418 (-3.4A);38Z A 418 ( 4.9A);None","1.17A","3hegA-4qtbA:37.3","3gp0A-4qtbA:45.74"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",6,"VAL A  56;ALA A  69;LYS A  71;GLU A  88;LEU A  92;ILE A 101","None;38Z A 418 (-3.4A);38Z A 418 (-2.9A);38Z A 418 (-3.4A);None;38Z A 418 ( 4.9A)","1.12A","3hegA-4qtbA:37.3","3hegA-4qtbA:47.41"],["3V5W_A_8PRA701_1","G-PROTEIN COUPLED RECEPTOR KINASE 2","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",6,"ILE A  48;GLY A  54;VAL A  56;ALA A  69;LYS A  71;LEU A 173","38Z A 418 ( 4.4A);None;None;38Z A 418 (-3.4A);38Z A 418 (-2.9A);38Z A 418 (-4.4A)","0.86A","3v5wA-4qtbA:8.7","3hegA-4qtbA:47.41"],["3WZE_A_BAXA1201_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",5,"VAL A 100;LEU A 173;ILE A 182;CYH A 183;ASP A 184","None;38Z A 418 (-4.4A);None;38Z A 418 ( 3.8A);38Z A 418 (-3.5A)","0.62A","3wzeA-4qtbA:21.5","3v5wA-4qtbA:22.16"],["3ZBF_A_VGHA3000_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",5,"ALA A  69;LEU A 124;MET A 125;ASP A 128;LEU A 173","38Z A 418 (-3.4A);38Z A 418 ( 4.8A);None;EDO A 413 (-2.9A);38Z A 418 (-4.4A)","0.55A","3zbfA-4qtbA:23.3","3wzeA-4qtbA:26.65"],["4ASD_A_BAXA1500_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",4,"ILE A  91;LEU A 173;ILE A 182;CYH A 183","None;38Z A 418 (-4.4A);None;38Z A 418 ( 3.8A)","0.81A","4asdA-4qtbA:21.1","3zbfA-4qtbA:25.19"],["4C8B_A_0LIA1000_1","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",7,"ALA A  69;LYS A  71;LEU A  92;ILE A 120;HIS A 164;LEU A 173;ASP A 184","38Z A 418 (-3.4A);38Z A 418 (-2.9A);None;None;None;38Z A 418 (-4.4A);38Z A 418 (-3.5A)","1.11A","4c8bA-4qtbA:22.0","4asdA-4qtbA:26.45"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",8,"VAL A  56;ALA A  69;ILE A 101;ASP A 128;ASP A 166;LYS A 168;ASN A 171;LEU A 173","None;38Z A 418 (-3.4A);38Z A 418 ( 4.9A);EDO A 413 (-2.9A);None;EDO A 405 ( 4.3A);None;38Z A 418 (-4.4A)","0.81A","4i41A-4qtbA:25.5","4c8bA-4qtbA:25.69"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",8,"VAL A  56;ILE A 101;ASP A 128;ASP A 166;LYS A 168;ASN A 171;LEU A 173;ASP A 184","None;38Z A 418 ( 4.9A);EDO A 413 (-2.9A);None;EDO A 405 ( 4.3A);None;38Z A 418 (-4.4A);38Z A 418 (-3.5A)","0.78A","4i41A-4qtbA:25.5","4i41A-4qtbA:25.74"],["4OGR_A_ADNA401_1","CYCLIN-DEPENDENT KINASE 9","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",6,"ILE A  48;VAL A  56;ALA A  69;ASP A 128;ASN A 171;LEU A 173","38Z A 418 ( 4.4A);None;38Z A 418 (-3.4A);EDO A 413 (-2.9A);None;38Z A 418 (-4.4A)","0.64A","4ogrA-4qtbA:31.1","4i41A-4qtbA:25.74"],["4OGR_I_ADNI401_1","CYCLIN-DEPENDENT KINASE 9","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",6,"ILE A  48;VAL A  56;ALA A  69;ASP A 128;ASN A 171;LEU A 173","38Z A 418 ( 4.4A);None;38Z A 418 (-3.4A);EDO A 413 (-2.9A);None;38Z A 418 (-4.4A)","0.65A","4ogrI-4qtbA:31.2","4ogrA-4qtbA:31.90"],["4U0I_A_0LIA1001_2","MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",7,"ALA A  69;LYS A  71;LEU A  92;HIS A 164;LEU A 173;CYH A 183;ASP A 184","38Z A 418 (-3.4A);38Z A 418 (-2.9A);None;None;38Z A 418 (-4.4A);38Z A 418 ( 3.8A);38Z A 418 (-3.5A)","1.17A","4u0iA-4qtbA:21.4","4ogrI-4qtbA:31.90"],["4XOY_A_DX4A401_0","MITOGEN-ACTIVATED PROTEIN KINASE 1","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",5,"ALA A  69;GLN A 122;LEU A 124;MET A 125;LEU A 173","38Z A 418 (-3.4A);38Z A 418 (-3.7A);38Z A 418 ( 4.8A);None;38Z A 418 (-4.4A)","0.21A","4xoyA-4qtbA:19.0","4u0iA-4qtbA:22.73"],["4XP3_A_DX4A401_0","MITOGEN-ACTIVATED PROTEIN KINASE 1","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",5,"ALA A  69;GLN A 122;LEU A 124;MET A 125;LEU A 173","38Z A 418 (-3.4A);38Z A 418 (-3.7A);38Z A 418 ( 4.8A);None;38Z A 418 (-4.4A)","0.32A","4xp3A-4qtbA:50.5","4xoyA-4qtbA:85.71"],["5HES_A_032A401_1","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",5,"VAL A  56;ALA A  69;ILE A 101;ILE A 120;CYH A 183","None;38Z A 418 (-3.4A);38Z A 418 ( 4.9A);None;38Z A 418 ( 3.8A)","0.68A","5hesA-4qtbA:20.3","4xp3A-4qtbA:85.71"],["5L2I_A_LQQA900_1","CYCLIN-DEPENDENT KINASE 6","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",7,"ILE A  48;GLY A  49;TYR A  53;VAL A  56;ALA A  69;ASP A 128;LEU A 173","38Z A 418 ( 4.4A);None;38Z A 418 (-3.5A);None;38Z A 418 (-3.4A);EDO A 413 (-2.9A);38Z A 418 (-4.4A)","0.75A","5l2iA-4qtbA:14.0","5hesA-4qtbA:27.11"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",6,"ILE A  48;GLY A  49;VAL A  56;ALA A  69;ILE A 101;MET A 125","38Z A 418 ( 4.4A);None;None;38Z A 418 (-3.4A);38Z A 418 ( 4.9A);None","0.62A","5lw1B-4qtbA:26.0","5l2iA-4qtbA:34.06"],["5LW1_E_ADNE401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",6,"GLY A  49;VAL A  56;ALA A  69;ILE A 101;LEU A 124;MET A 125","None;None;38Z A 418 (-3.4A);38Z A 418 ( 4.9A);38Z A 418 ( 4.8A);None","0.54A","5lw1E-4qtbA:24.6","5lw1B-4qtbA:10.46"],["5LW1_H_ADNH401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",5,"GLY A  49;VAL A  56;ALA A  69;LEU A 124;MET A 125","None;None;38Z A 418 (-3.4A);38Z A 418 ( 4.8A);None","0.41A","5lw1H-4qtbA:37.8","5lw1E-4qtbA:10.46"],["5VLM_F_CVIF301_1","REGULATORY PROTEIN TETR","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",4,"ILE A  91;GLN A 122;VAL A 100;ASP A 227","None;38Z A 418 (-3.7A);None;None","1.14A","5vlmF-4qtbA:undetectable","5lw1H-4qtbA:10.46"],["6FNM_A_1N1A1001_1","-","4qtb","MITOGEN-ACTIVATED PROTEIN KINASE 3","Homo sapiens",7,"ILE A  48;VAL A  56;ALA A  69;GLU A  88;ILE A 120;MET A 125;LEU A 173","38Z A 418 ( 4.4A);None;38Z A 418 (-3.4A);38Z A 418 (-3.4A);None;None;38Z A 418 (-4.4A)","0.88A","6fnmA-4qtbA:17.3","5vlmF-4qtbA:20.16"]]